Evidence map›Paper›PMID 42345027›Full record

ArticleGeburtshilfe und Frauenheilkunde2026

Feasibility of

Hanne Grollmann, Barbara Volz, Werner Schroth, Veronika Bahlinger, Andreas Hartkopf, Sara Y Brucker, Léa L Volmer, André Koch

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Geburtshilfe und Frauenheilkunde, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hanne GrollmannResearch Institute for Women's HealthUniversity of TübingenTübingenGermany.ORCID 0009-0001-9774-7252
Barbara VolzResearch Institute for Women's HealthUniversity of TübingenTübingenGermany.
Werner SchrothDr. Magarete Fischer-Bosch Institute of Clinical PharmacologyStuttgartBaden-WürttembergGermany.
Veronika BahlingerDepartement of General and Molecular Pathology and Pathological Anatomy TübingenUniversity of Tübingen Institute of PathologyTübingenBWGermany.
Andreas HartkopfResearch Institute for Women's HealthUniversity of TübingenTübingenGermany.
Sara Y BruckerResearch Institute for Women's HealthUniversity of TübingenTübingenGermany.
Léa L VolmerResearch Institute for Women's HealthUniversity of TübingenTübingenGermany.
André KochResearch Institute for Women's HealthUniversity of TübingenTübingenGermany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Disseminated tumor cells originating from the bone marrow serve as precursors of distant metastasis and are associated with increased mortality in breast cancer. With the emergence of targeted therapies for breast cancer, accurate procedures for enrichment of disseminated tumor cells are crucial to investigate the molecular heterogeneity between disseminated tumor cells and primary tumors. This study evaluated the feasibility of

Indexed as

breast cancerdigital droplet PCR (ddPCR)disseminated tumor cells (DTCs)liquid biopsyParsortix

Identifiers

PMID42345027
PMCPMC13287949

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.